These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 12429976

  • 1. Mifepristone-induced secretion of transforming growth factor beta1-induced apoptosis in prostate cancer cells.
    Liang Y, Eid MA, El Etreby F, Lewis RW, Kumar MV.
    Int J Oncol; 2002 Dec; 21(6):1259-67. PubMed ID: 12429976
    [Abstract] [Full Text] [Related]

  • 2. Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1.
    Liang Y, Hou M, Kallab AM, Barrett JT, El Etreby F, Schoenlein PV.
    Int J Oncol; 2003 Aug; 23(2):369-80. PubMed ID: 12851686
    [Abstract] [Full Text] [Related]

  • 3. Differential expression of members of the tumor necrosis factor alpha-related apoptosis-inducing ligand pathway in prostate cancer cells.
    Sridhar S, Ali AA, Liang Y, El Etreby MF, Lewis RW, Kumar MV.
    Cancer Res; 2001 Oct 01; 61(19):7179-83. PubMed ID: 11585752
    [Abstract] [Full Text] [Related]

  • 4. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y, Kyprianou N.
    Cancer Res; 1999 Mar 15; 59(6):1366-71. PubMed ID: 10096572
    [Abstract] [Full Text] [Related]

  • 5. FLICE-like inhibitory protein blocks transforming growth factor beta 1-induced caspase activation and apoptosis in prostate epithelial cells.
    Nastiuk KL, Yoo K, Lo K, Su K, Yeung P, Kutaka J, Danielpour D, Krolewski JJ.
    Mol Cancer Res; 2008 Feb 15; 6(2):231-42. PubMed ID: 18314484
    [Abstract] [Full Text] [Related]

  • 6. The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway.
    Jiang J, Sugimoto Y, Liu S, Chang HL, Park KY, Kulp SK, Lin YC.
    Anticancer Res; 2004 Feb 15; 24(1):91-100. PubMed ID: 15015581
    [Abstract] [Full Text] [Related]

  • 7. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S, Mitchell JB, Samuni A, Mueller S, Kasid U.
    Cancer; 2005 Mar 15; 103(6):1302-13. PubMed ID: 15685617
    [Abstract] [Full Text] [Related]

  • 8. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer.
    van der Poel HG.
    Eur Urol; 2005 Dec 15; 48(6):1051-8. PubMed ID: 16257107
    [Abstract] [Full Text] [Related]

  • 9. Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture.
    El Etreby MF, Liang Y, Lewis RW.
    Prostate; 2000 Apr 01; 43(1):31-42. PubMed ID: 10725863
    [Abstract] [Full Text] [Related]

  • 10. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L, Fine RL, Do TN, Douglas GP, Petrylak DP.
    Clin Cancer Res; 2002 Dec 01; 8(12):3922-32. PubMed ID: 12473608
    [Abstract] [Full Text] [Related]

  • 11. Caspase-dependent apoptosis induction by phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent, is mediated by Bak and Bax.
    Xiao D, Zeng Y, Choi S, Lew KL, Nelson JB, Singh SV.
    Clin Cancer Res; 2005 Apr 01; 11(7):2670-9. PubMed ID: 15814648
    [Abstract] [Full Text] [Related]

  • 12. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts.
    Samsel L, Zaidel G, Drumgoole HM, Jelovac D, Drachenberg C, Rhee JG, Brodie AM, Bielawska A, Smyth MJ.
    Prostate; 2004 Mar 01; 58(4):382-93. PubMed ID: 14968439
    [Abstract] [Full Text] [Related]

  • 13. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
    Liu CM, Lo YC, Tai MH, Wu BN, Wu WJ, Chou YH, Chai CY, Huang CH, Chen IJ.
    Prostate; 2009 May 01; 69(6):610-23. PubMed ID: 19143029
    [Abstract] [Full Text] [Related]

  • 14. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
    Thelen P, Schweyer S, Hemmerlein B, Wuttke W, Seseke F, Ringert RH.
    Int J Oncol; 2004 Jan 01; 24(1):25-31. PubMed ID: 14654937
    [Abstract] [Full Text] [Related]

  • 15. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K, Mizokami A, Li YQ, Narimoto K, Sugimoto K, Kadono Y, Kitagawa Y, Konaka H, Koh E, Keller ET, Namiki M.
    Prostate; 2009 Aug 01; 69(11):1222-34. PubMed ID: 19434660
    [Abstract] [Full Text] [Related]

  • 16. Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells.
    El Etreby MF, Liang Y, Wrenn RW, Schoenlein PV.
    Breast Cancer Res Treat; 1998 Sep 01; 51(2):149-68. PubMed ID: 9879777
    [Abstract] [Full Text] [Related]

  • 17. Bcl-2 antagonizes the combined apoptotic effect of transforming growth factor-beta and dihydrotestosterone in prostate cancer cells.
    Bruckheimer EM, Kyprianou N.
    Prostate; 2002 Oct 01; 53(2):133-42. PubMed ID: 12242728
    [Abstract] [Full Text] [Related]

  • 18. [Induction of apoptosis by mifepristone in androgen-independent prostate cancer cell lines in vitro].
    Zhang H, Lü JJ, Gao QZ, Zhang J.
    Zhonghua Wai Ke Za Zhi; 2006 Mar 15; 44(6):382-5. PubMed ID: 16638347
    [Abstract] [Full Text] [Related]

  • 19. Mitochondria from TRAIL-resistant prostate cancer cells are capable of responding to apoptotic stimuli.
    Liang Y, Eid MA, Lewis RW, Kumar MV.
    Cell Signal; 2005 Feb 15; 17(2):243-51. PubMed ID: 15494215
    [Abstract] [Full Text] [Related]

  • 20. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.
    Shankar S, Singh TR, Srivastava RK.
    Prostate; 2004 Sep 15; 61(1):35-49. PubMed ID: 15287092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.